Physician profile
Max Plitt
NPI 1497137699
$1,639.82
in general payments reported to CMS, 2019-2025
10 companies · $815 in 2025
The $815 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $234 · 2021: $268 · 2022: $129 · 2023: $33.74 · 2024: $160 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $773.32 | 2024-2025 | Inspire |
| Stryker Corporation | $422.93 | 2020-2025 | Audion Et Dilation System |
| Genzyme Corporation | $122.18 | 2021 | |
| Glaxosmithkline, LLC. | $102.45 | 2025 | Nucala |
| Smith+Nephew, INC. | $49.33 | 2020 | |
| Intersect Ent, INC. | $45.85 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.63 | 2024 | Dupixent |
| Aerin Medical INC. | $34.98 | 2020 | |
| Davol INC. | $33.74 | 2023 | |
| Atos Medical INC | $18.41 | 2025 | Provox Life Home Hme |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Plitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.